Clinical Efficacy, Cost-effectiveness and Mechanistic Evaluation of aflibercept for Proliferative Diabetic Retinopathy (acronym CLARITY): a noninferiority randomised trial
Research output: Book/Report › Commissioned report
NIHR Efficacy and Mechanistic Evaluation (EME) Programme Report
| Original language | English |
|---|---|
| Publisher | NIHR |
| Publication status | Published - Jan 2018 |